Shares moved sharply: Ryan Specialty closed at $44.10, down 5.2% on July 30.

That looks at odds with a company that grew revenue 21.9% last year to $3.0B — but the headline growth masks a big spread between what the business makes and what ends up on the bottom line. Operating margin is +16.5%; net margin is +2.1% — a gap of 14.4 percentage points.

Management’s filing lays out how it measures growth before you read too much into the top-line number:

"Organic Revenue Growth Rate Organic revenue growth rate is defined as the percentage change in Net commissions and fees, as compared to the same period for the prior year, adjusted to eliminate revenue attributable to acquisitions for the first twelve months of ownership, revenue attributable to sold businesses for the subsequent twelve months after the sale, and other items such as contingent commissions and the impact of changes in foreign exchange rates." (Ryan Specialty Holdings, Inc. / 10-Q 2026-07-31)

That means the company’s growth figures are presented after stripping out acquisitions, divestitures, contingent commissions and FX — useful when you’re trying to tell organic growth from deal-driven moves.

The file also calls out restructuring and related costs in G&A — and a modest increase tied, management says, to growth:

"Restructuring expense within General and administrative expense includes costs relating to professional services, 42 technology and data initiatives, license fees, and third-party contractors, as well as non-cash expenses associated with the impairment of internally-developed software; and • A $10.6 million increase was driven by growth in the business." (Ryan Specialty Holdings, Inc. / 10-Q 2026-07-31)

Put the pieces together and you get two competing stories. The long-case evidence: revenue climbed from $765.1M in 2019 to $3.0B in 2025, latest-year growth was +21.9%, the company’s operating margin is a healthy +16.5%, operating cash flow covered net income at 10.15x in the latest annual period, and filings repeatedly note favorable foreign-exchange effects and cost-reduction work.

The short-case evidence is blunt as well: net margin fell by 1.7 percentage points in the latest year to just +2.1%, and the balance sheet carries $3.1B of net debt. The market has shown skepticism — the stock is down 7.3% over six months and 26.5% over the past year.

So the tension is mechanical. Ryan is growing quickly and converting a fair chunk of revenue into operating profit, but a much smaller share makes it to net income after restructuring, other G&A items, interest and non-cash charges. That gap is the knob traders pushed on: a single top-line stream can look very different depending on how those subtractions behave.

No verdict here — just a narrow arithmetic fact: fast growth plus a big operating-to-net gap equals a wide range of possible outcomes for valuation, and the market’s recent trading reflects that disagreement.

Revenue $3.0B and net debt $3.1B per company filings (10-Q 2026-07-31).